JP2025532676A5 - - Google Patents
Info
- Publication number
- JP2025532676A5 JP2025532676A5 JP2025517344A JP2025517344A JP2025532676A5 JP 2025532676 A5 JP2025532676 A5 JP 2025532676A5 JP 2025517344 A JP2025517344 A JP 2025517344A JP 2025517344 A JP2025517344 A JP 2025517344A JP 2025532676 A5 JP2025532676 A5 JP 2025532676A5
- Authority
- JP
- Japan
- Prior art keywords
- ngf
- pharmaceutical composition
- use according
- mutant protein
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22197562.6 | 2022-09-23 | ||
| EP22197562.6A EP4342485A1 (en) | 2022-09-23 | 2022-09-23 | Ngf for the treatment of spasticity |
| PCT/EP2023/076387 WO2024062135A1 (en) | 2022-09-23 | 2023-09-25 | Ngf for the treatment of spasticity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025532676A JP2025532676A (ja) | 2025-10-01 |
| JP2025532676A5 true JP2025532676A5 (cg-RX-API-DMAC10.html) | 2026-04-28 |
Family
ID=83438536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025517344A Pending JP2025532676A (ja) | 2022-09-23 | 2023-09-25 | 痙縮治療のためのｎｇｆ |
Country Status (10)
| Country | Link |
|---|---|
| EP (3) | EP4342485A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025532676A (cg-RX-API-DMAC10.html) |
| CN (1) | CN120239610A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023345675A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3266315A1 (cg-RX-API-DMAC10.html) |
| DK (1) | DK4590324T3 (cg-RX-API-DMAC10.html) |
| FI (1) | FI4590324T3 (cg-RX-API-DMAC10.html) |
| IL (1) | IL319010A (cg-RX-API-DMAC10.html) |
| PT (1) | PT4590324T (cg-RX-API-DMAC10.html) |
| WO (1) | WO2024062135A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4623927A1 (en) | 2024-03-27 | 2025-10-01 | Dompe' Farmaceutici SpA | Ngf for use in the prevention or treatment of motor impairment caused by neonatal hypoxic-ischemic encephalopathy |
| WO2026022244A1 (en) | 2024-07-23 | 2026-01-29 | Chiesi Farmaceutici S.P.A. | A polypeptide for use in the therapeutic management of acute ischaemic stroke |
| US20260166124A1 (en) * | 2024-12-17 | 2026-06-18 | Dompe` farmaceutici S.P.A. | Intranasal administration of ngf for the prevention or treatment of retinopathies and optic nerve disorders |
| EP4763217A1 (en) * | 2024-12-17 | 2026-06-24 | Dompé farmaceutici SpA | Intranasal administration of ngf for the prevention or treatment of retinopathies and optic nerve disorders |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE257514T1 (de) | 1998-10-09 | 2004-01-15 | Scil Proteins Gmbh | Verfahren zur gewinnung von aktivem beta-ngf |
| CN1112215C (zh) * | 1999-12-28 | 2003-06-25 | 潘晓东 | 神经生长因子在治疗有机溶剂中毒性周围神经病中的用途 |
| ES2545701T3 (es) | 2011-12-19 | 2015-09-15 | Wacker Chemie Ag | Nuevos mutantes de proNGF y usos de los mismos en la producción de beta-NGF |
| CN109071678B (zh) * | 2016-03-18 | 2022-05-20 | 舒泰神（北京）生物制药股份有限公司 | 神经生长因子融合蛋白、制备方法及其用途 |
| IT201600112420A1 (it) * | 2016-11-08 | 2018-05-08 | Univ Cattolica Del Sacro Cuore | Nuova formulazione per via intranasale |
| WO2019207106A1 (en) | 2018-04-27 | 2019-10-31 | Chiesi Farmaceutici Spa | Production of nerve growth factor (ngf) and of muteins thereof |
| AU2020347812B2 (en) * | 2019-09-17 | 2026-05-28 | Chiesi Farmaceutici S.P.A. | Agent for use in treatment or prevention of ophthalmic disorders |
| WO2022105847A1 (en) * | 2020-11-19 | 2022-05-27 | Staidson (Beijing) Biopharmaceuticals Co. , Ltd. | Long-acting nerve growth factor polypeptides and uses thereof |
-
2022
- 2022-09-23 EP EP22197562.6A patent/EP4342485A1/en not_active Withdrawn
-
2023
- 2023-09-25 FI FIEP23777211.6T patent/FI4590324T3/fi active
- 2023-09-25 DK DK23777211.6T patent/DK4590324T3/da active
- 2023-09-25 PT PT237772116T patent/PT4590324T/pt unknown
- 2023-09-25 EP EP23777211.6A patent/EP4590324B1/en active Active
- 2023-09-25 IL IL319010A patent/IL319010A/en unknown
- 2023-09-25 WO PCT/EP2023/076387 patent/WO2024062135A1/en not_active Ceased
- 2023-09-25 AU AU2023345675A patent/AU2023345675A1/en active Pending
- 2023-09-25 CN CN202380067388.4A patent/CN120239610A/zh active Pending
- 2023-09-25 CA CA3266315A patent/CA3266315A1/en active Pending
- 2023-09-25 JP JP2025517344A patent/JP2025532676A/ja active Pending
- 2023-09-25 EP EP26179026.5A patent/EP4772196A3/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0694307B1 (en) | Atopic disease remedy | |
| EP0614369B1 (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| JP2961709B2 (ja) | 呼吸器系疾患の治療方法および治療用薬剤組成物 | |
| JP3250804B2 (ja) | 治療用ペプチド | |
| JP2023123440A (ja) | 合成リジンアナログ及び模倣物の抗ウイルス用途のための方法及び組成物 | |
| KR20240032789A (ko) | 시클로-히스프로를 유효성분으로 포함하는 비만 예방 또는 치료용 약제학적 조성물 | |
| AU668088B2 (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| CN1917898B (zh) | 用于治疗间质肺部感染的血管活性肠肽的生物活性物质 | |
| JP2007119497A (ja) | インターフェロン−ガンマスティミュレーター含有医薬組成物 | |
| JP2003226639A (ja) | 神経成長因子活性増強剤としてのビタミンｋ類を含む医薬組成物およびその使用 | |
| EP0149254A2 (en) | Fungicidal polypeptide compositions containing L-histidine | |
| CA2323213C (en) | Treatment of respiratory disease and otitis media | |
| RU2025110129A (ru) | Ngf для лечения спастичности | |
| KR100302994B1 (ko) | 약독화된비면역원성폭스바이러스또는파라폭스바이러스로부터멀티포텐트파라폭스면역유발인자의약제로서이용하는새로운적용 | |
| EP0080032A2 (en) | Pharmaceutical preparation for treating herpetic lesions | |
| CA2782779A1 (en) | Mucoadhesive buccal tablets for the treatment of orofacial herpes | |
| JP2022518527A5 (cg-RX-API-DMAC10.html) | ||
| AU1392301A (en) | Interferon gamma for the treatment of asthma | |
| CZ234098A3 (cs) | Farmaceutický výrobek | |
| CN104510752B (zh) | 紫檀烷苷的医药用途 | |
| CZ20023245A3 (cs) | Farmaceutický prostředek | |
| JP2025503251A5 (cg-RX-API-DMAC10.html) | ||
| JP2002531495A (ja) | ウイルス疾患を処置するためのビュープロピオン | |
| EP0761229B1 (en) | Corneal vascularization inhibitor | |
| JPH0415766B2 (cg-RX-API-DMAC10.html) |